Senseonics Initiates First-in-Human Study of Freedom, Designed to be the World’s First CGM System with No On-body Component
Senseonics Initiates First-In-Human Study Of Freedom
Senseonics Holdings, Inc. to Participate in Upcoming Investor Conferences
Sensirion (SWX:SENS) Stock May Trade At A Premium To Cash Flow
Senseonics Holdings, Inc. Schedules Third Quarter 2026 Earnings Release and Conference Call for November 9, 2026 at 4:30 P.M. Eastern Time
Senseonics Holdings Q2 2026 Earnings Call: Complete Transcript
Barclays Initiates Coverage On Senseonics Holdings with Equal-Weight Rating, Announces Price Target of $10
Senseonics Announces Strategic Partnership with Beta Bionics to Integrate Eversense® 365 with the iLet® Bionic Pancreas
Senseonics Partners With Beta Bionics To Integrate Its Eversense 365 CGM With Beta Bionics’ iLet Bionic Pancreas Automated Insulin Delivery System
Senseonics To Participate in Upcoming Institutional Investor Conferences
Sensirion Holding AG (XSWX:SENS) (H1 2026) Earnings Call Highlights: Broad-Based Growth and ...
Senseonics Holdings, Inc. Common Stock Q2 Earnings Call Highlights
Senseonics Holdings Inc (SENS) (Q2 2026) Earnings Call Highlights: Revenue Soars 120% as ...
Senseonics Holdings, Inc. (SENS) Q2 2026 Earnings Call Transcript
Senseonics Holdings (SENS) Reports Q2 Loss, Tops Revenue Estimates
Senseonics Holdings (NASDAQ:SENS) Jumps on Q2 Revenue Beat and Raised Full-Year Guidance
Senseonics Holdings, Inc. Reports Second Quarter 2026 Financial Results
Senseonics Holdings Raises FY2026 Sales Guidance from $60.000M-$64.000M to $62.000M-$66.000M vs $62.117M Est
Senseonics Holdings Q2 EPS $(0.63), Inline, Sales $14.483M Beat $12.871M Estimate
Senseonics Holdings, Inc. Schedules Second Quarter 2026 Earnings Release and Conference Call for August 6, 2026 at 4:30 P.M. Eastern Time
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.